Dumont P, Petein M, Lespagnard L, Tueni E, Coune A
Laboratory for Experimental Chemotherapy, Institut Jules Bordet, Brussels, Belgium.
In Vivo. 1993 Mar-Apr;7(2):167-70.
The tumourigenicity of the LNCaP prostatic cell line was investigated in vivo after prostatic (orthotopic), subcutaneous (ectopic) and concomitant implantations in male Balb/c nude mice. Swollen lymph nodes were detected in the inguinal region only after subcutaneous implantation but could not be characterized by immunohistochemistry. However, when grafted to Endoxan-pretreated mice, they generated well differentiated tumours which secreted prostate-specific acid phosphatase. A parallel study was conducted to investigate the metastatic potential of the LNCaP tumour using several routes of implantation (intravenous, bone contact, intrasplenic and intracranial). Tumours grew only after intracranial implantation. No production of either haematogenous or bony metastases was recorded.
在雄性Balb/c裸鼠中进行前列腺(原位)、皮下(异位)和同步植入后,对LNCaP前列腺癌细胞系的致瘤性进行了体内研究。仅在皮下植入后,腹股沟区域检测到肿大的淋巴结,但无法通过免疫组织化学进行特征描述。然而,当移植到用环磷酰胺预处理的小鼠体内时,它们产生了分泌前列腺特异性酸性磷酸酶的高分化肿瘤。进行了一项平行研究,使用几种植入途径(静脉内、骨接触、脾内和颅内)来研究LNCaP肿瘤的转移潜能。仅在颅内植入后肿瘤生长。未记录到血行转移或骨转移的发生。